ACE2冠状病毒受体的遗传特征
Zhijian Yang1,2, Erin Macdonald-Dunlop3, Jiantao Chen1,2
1Biostatistics Group, School of Life Sciences, Sun Yat-sen University, Guangzhou, China (Z.Y., J.C., R.Z., T.L., Z.N., C.Z., Y.W., X.S.).
这项研究显示,遗传因素影响血管激素转化酶2 (ACE2) 水平,影响COVID-19的严重程度和心血管疾病的风险. 了解ACE2基因对于开发针对性的冠状病毒治疗至关重要.
科学领域:
- 遗传学
- 心血管生物学
- 传染性疾病
背景情况:
- 血管激素转化酶2 (ACE2) 蛋白质对于SARS-CoV-2进入人体细胞至关重要,使其成为COVID-19治疗的关键目标.
- ACE2在心血管和其他生物系统中起着重要作用,但其遗传基础仍然不太清楚.
研究的目的:
- 研究血ACE2蛋白水平的遗传基础.
- 探索ACE2水平与心脏代谢表型,COVID-19和其他复杂特征之间的遗传相关性.
- 评估可溶性ACE2对血管疾病和COVID-19严重性的因果关系.
主要方法:
- 在28000多个个体中进行了血ACE2水平的大规模基因组协会元分析.
- 使用高清概率方法来估计遗传相关性.
- 进行了孟德尔随机化和形功能分析,整合了多种数据.
主要成果:
- 确定了与ACE2水平相关的10个遗传位点,解释了其30%的遗传性.
- 在血ACE2与血管疾病,严重的COVID-19以及各种复杂疾病/药物之间发现了显著的遗传相关性.
- 孟德尔的随机化表明,高ACE2水平会导致COVID-19的严重程度,住院和感染的风险增加.
结论:
- 血ACE2水平与心血管疾病和COVID-19具有共同的遗传基础.
- 绘制的ACE2基因架构为未来对这一关键冠状病毒受体的研究提供了宝贵的资源.
更多相关视频
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
相关概念视频
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
GPCRs Regulate Adenylyl Cylase Activity
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
